|
Tello-Montoliu A, Marín F. [Biomarkers in risk stratification of acute coronary syndrome without ST elevation: is there anything after troponin?]. Med Clin (Barc). 2009 Oct 24;133(15):586-8. doi: 10.1016/j.medcli.2009.07.015. Epub 2009 Oct 4. Spanish. PubMed PMID: 19804891.
AÑO: 2009; IF: 1.231
|
19804891
|
Sandín M, Marín F, Cambronero F, Climent V, Caro C, Martínez JG, Honrubia AG, García Alberola A, de la Morena G, Valdés M, Sogorb F. Does pacemaker implantation provide long-term benefits in severe obstructive hypertrophic cardiomyopathy? Rev Esp Cardiol. 2009 Nov;62(11):1233-9. PubMed PMID: 19889334.
AÑO: 2009; IF: 2.746
|
|
Gimeno JR, Monserrat L, Pérez-Sánchez I, Marín F, Caballero L, Hermida-Prieto M, Castro A, Valdés M. Hypertrophic cardiomyopathy. A study of the troponin-T gene in 127 Spanish families. Rev Esp Cardiol. 2009 Dec;62(12):1473-7. PubMed PMID: 20038417.
AÑO: 2009; IF: 2.746
|
|
Marín F, Bonacasa B, Valdés M. Glycoprotein inhibitors in patients on chronic anticoagulation: safe enough or too much risk? Thromb Haemost. 2010 Jan;103(1):11-2. doi: 10.1160/TH09-10-0694. Epub 2009 Dec 1. PubMed PMID: 20062940.
AÑO: 2010; IF: 6.681
|
|
Tello-Montoliu A, Marín F, Roldán V, Lip GY. The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage? Heart. 2010 Feb;96(3):227-8; author reply 228. doi: 10.1136/hrt.2009.182105. PubMed PMID: 20133421.
AÑO: 2010; IF: 4.708
|